← Eichor
Condition: Asc Us Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Asc Us

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase II Study of Dysplasix™ Intravaginal Suppositories in Patients Patients With High-Risk HPV and Mild Cervical Cytolo
Phase 2 · 1 location(s) · Amplexd Therapeutics, Inc. · NCT07572396Study of Treatment for HPV16+ ASC-US or LSIL
Phase 1 · 2 location(s) · University of Alabama at Birmingham · NCT03913117Phase 1 Dose-escalation Study of FluBHPVE6E7 in HPV16-infected Women
Phase 1 · 1 location(s) · BlueSky Immunotherapies GmbH · NCT05829629Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
NA · 1 location(s) · Timser SAPI de CV · NCT07480902
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.